arrow
D

Diego A. Pizzagalli

institute for translational depression discoveries
H指数:97
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression

更正:斯坦福神经调控疗法在难治性抑郁症中的神经生理学特征

2026-10-190
OAAI
Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression

斯坦福神经调控疗法在难治性抑郁症治疗中的神经生理学特征

2026-09-020
OAAI
Investigating functional connectivity differences during food vs. monetary reward processing across appetitive phenotypes of major depressive disorder

探究主要抑郁症不同食欲表型在食物与金钱奖励处理期间的功能连接差异

2026-07-010
PRE
Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

多巴胺激动剂普拉克索治疗无症状性抑郁症的疗效和靶点参与: 一项随机安慰剂对照试验

2026-06-120
OAAI
Detrended fluctuation analysis of amygdala-hippocampal beta synchrony reveals network rigidity in depression associated with temporal lobe epilepsy

杏仁核-海马体β同步的去趋势波动分析揭示了与颞叶癫痫相关的抑郁症中的网络刚性

2026-05-050
OAAI
Corrigendum to “Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies”, EBioMedicine. 2025 Nov;121:105967. doi: 10.1016/j.ebiom.2025.105967

勘误:发表于EBioMedicine期刊的“用于抑郁症快感缺乏的促多巴胺能药理学干预:一项活体系统评价和网络荟萃分析(涵盖人类和动物研究)”,2025年11月;121:105967。doi: 10.1016/j.ebiom.2025.105967

2025-12-160
OAAI
ENX-104: a selective and potent D2/D3 receptor antagonist enhances dopamine neurotransmission and reward responsiveness in translational rodent models

ENX-104:一种选择性且高效的D2/D3受体拮抗剂,能够增强多巴胺能神经传递并对奖励反应产生作用,在转化型啮齿动物模型中得到验证。

2025-12-070
OAAI